NeuroPace Announces FDA Submission of Three-Year Data From Post-Approval Study of the RNS System in Focal Epilepsy

GlobeNewswire11/05 05:05

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

GlobeNewswire10/23 04:05

Press Release: NeuroPace Strengthens Management Team With Two Key Appointments

Dow Jones09/05 04:05

NeuroPace to Participate in Upcoming Healthcare Conferences in September

GlobeNewswire08/23 04:05

NeuroPace Second Quarter 2024 Earnings: Beats Expectations

Yahoo Finance08/20 18:13

Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57

Yahoo Finance08/16 19:33